However, TET1 and TET3 down-regulation sensitizes the breast tumor-initiating cells to paclitaxel and decreases the tumor growth and metastasis in vivo through down-regulation of the TNFα-p38-MAPK signaling pathway [49]. Here, TET1 is linked to neoplasm.